NASHVILLE, Tenn., Sept. 10, 2019 /PRNewswire/ -- OneOncology physicians and leaders are studying the implications of risk-based payments to ensure oncology partner practices remain at the forefront of value-based care. As the transition from fee-for-service to value-based care by both commercial payers and the Centers for Medicare and Medicaid Services (CMS) picks up momentum, OneOncology is focused on positioning its practices for success in any reimbursement environment.
"The future of oncology is based in value not volume," said Dr. Jeffrey Patton, President of Physician Services for OneOncology and CEO of Tennessee Oncology. "While the high-quality and lower-cost provider should succeed in value-based arrangements, we will only truly thrive if we are leading the market through implementation, research and education. OneOncology is committed to fully understanding different alternative risk models and helping our physician practice partners have a line of sight into all of the implications these models pose, so we can continue to chart the course of oncology's future."
OneOncology partner practices are leaders in value-based care implementation as part of the Centers for Medicare and Medicaid Services' (CMS) Oncology Care Model (OCM) or with various commercial payers.
Physicians and experts from OneOncology's founding practices, New York Cancer & Blood Specialists, Tennessee Oncology and West Cancer Center, unveiled a fall conference schedule at which key leaders across clinical, operational and practice administrative functions are participating in numerous discussions to share key learnings about implementing value-based care initiatives.
"These conferences are an ideal way to share what we're learning so as a community we're shaping, and not reacting to, the future of oncology," Dr. Patton said.
The schedule is as follows:
Conference | Date & Location | Topic | Subject Matter Expert |
Value-based Oncology | Oct. 3-4, | Aaron Lyss, | |
Oncology Clinical
| Oct. 11, Boston, MA | Provider Integration/Consolidation in the Oncology | Dr. Lee Schwartzberg, Chief Medical Officer, OneOncology |
Association for Value-
| Oct. 17-18,
| Liquid Biopsy: Clinical-Economic Considerations for
Navigating Future Innovation and Legacy Challenges
Data Information Needs for the Cancer Care | Dr. Lee Schwartzberg, Chief Medical Officer, OneOncology
Aaron Lyss, |
AJMC's Institute for | Oct. 24, Nashville, TN | The Future of Oncology Value-Based Care
| Dr. Stephen Schleicher,
Aaron Lyss, |
AJMC's Patient | Nov. 8, | Innovation and Quality: New Directions in Value | Dr. Jeff Patton, CEO, Tennessee Oncology
Erich Mounce, Chief |
About OneOncology:
OneOncology is a national partnership of independent, community oncology practices working together to improve the lives of everyone living with cancer through a physician-led, data-driven, technology-powered and patient-centric model. OneOncology is comprised of four large community oncology practices representing over 250 physicians practicing at more than 100 sites of care across the United States. To learn more, visit oneoncology.com or LinkedIn.
SOURCE OneOncology
